Insider Trading Alert - BG, CIEN And CAK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 12, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $40.83 to $3,226,332.72.

Highlighted Stocks Traded by Insiders:

Bunge (BG) - FREE Research Report

Lupo L Patrick, who is Director at Bunge, bought 3,000 shares at $79.65 on March 12, 2015. Following this transaction, the Director owned 20,730 shares meaning that the stake was boosted by 16.92% with the 3,000-share transaction.

The shares most recently traded at $79.91, up $0.26, or 0.33% since the insider transaction. Historical insider transactions for Bunge go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 5,118
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 5,118
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 5,118

The average volume for Bunge has been 967,900 shares per day over the past 30 days. Bunge has a market cap of $11.5 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 12.37% year-to-date as of the close of trading on Thursday.

Bunge Limited, through its subsidiaries, is engaged in agriculture and food businesses worldwide. It operates through five segments: Agribusiness, Sugar and Bioenergy, Edible Oil Products, Milling Products, and Fertilizer. The stock currently has a dividend yield of 1.72%. The company has a P/E ratio of 26.6. Currently, there are 2 analysts who rate Bunge a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BG - FREE

TheStreet Quant Ratings rates Bunge as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Bunge Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Learn to Love Selloffs

M&A and Dividends Provide Reasons to Dig European Miners

Grain Glut Has Bunge Searching Couch Cushions for Loose Change

Bunge Stock Rises After It Hires JPMorgan and Shearman & Sterling to Defend Against Takeover Bid

Stocks Add to Gains as Fed Supports Balance Sheet Reduction, Rate Hike 'Soon'